Xiaohui Wu

Prof. Xiaohui Wu

Tianjin Medical University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XWXiaohui Wu
Xiaohui Wu
JRJin-Lan Ruan
Jin-Lan Ruan
JZJun Zhang
Jun Zhang
SWShu-Qing Wang
Shu-Qing Wang
YZYan-Wen Zhang
Yan-Wen Zhang

1 February 2022 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ZYZijun Yang
Zijun Yang
DWDan Wang
Dan Wang
YLYuanyuan Li
Yuanyuan Li
XZXinfeng Zhou
Xinfeng Zhou
TLTiantian Liu
Tiantian Liu
XWXiaohui Wu
Xiaohui Wu
Red ginseng is a traditional Chinese herbal medicine that has long been used to treat diabetes, and its blood sugar-lowering activity has been confirmed. However, the mechanism of action of red ginseng on type 2 diabetes mellitus (T2DM) at the metabolic level is still unclear. The purpose of this study is to investigate the effect of red ginseng extract in the treatment of T2DM rats based on untargeted metabolomics. The rat model of T2DM was induced by a high-fat diet (HFD) combined with streptozotocin (STZ), and serum samples were collected after four weeks of treatment. The ultra-high-performance liquid chromatography coupled with Q Exactive HF-X Mass Spectrometer was used to analyze the level of metabolites in serum to evaluate the differences in metabolic levels between different groups. The results of biochemical analysis showed that red ginseng extract intervention significantly improved the levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), serum glucose (GLU), and fasting insulin (FINS) after four weeks. Orthogonal partial least squares discriminant analysis was used to study the overall changes of rat metabolomics. After the intervention of red ginseng extract, 50 biomarkers showed a callback trend. Metabolic pathway enrichment analysis showed that the regulated pathways were D-arginine and D-ornithine metabolism, D-glutamine and D-glutamate metabolism, taurine and hypotaurine metabolism, arginine biosynthesis, and tryptophan metabolism. Generally, the results demonstrated that red ginseng extract had beneficial effects on T2DM, which could be mediated via ameliorating the metabolic disorders.

1 September 2015 in Fitoterapia
Verified
Journal Article
Closed access
PHPi-Yong Hou
Pi-Yong Hou
CMChao Mi
Chao Mi
YHYi He
Yi He
JZJun Zhang
Jun Zhang
SWShu-Qing Wang
Shu-Qing Wang
XWXiaohui Wu
Xiaohui Wu

17 August 2020 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
SZShunming Zhang
Shunming Zhang
XWXiaohui Wu
Xiaohui Wu
SBShanshan Bian
Shanshan Bian
QZQing Zhang
Qing Zhang
LLLi Liu
Li Liu
Kaijun NiuKaijun Niu
Kaijun Niu
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Recent evidence has suggested the protective effects of honey consumption against the metabolic syndrome, but the association between honey intake and NAFLD is still unclear. We investigated how the consumption frequency of honey was associated with NAFLD in the general population. This was a cross-sectional study of 21 979 adults aged 20–90 years. NAFLD was diagnosed based on the ultrasound-diagnosed fatty liver without significant alcohol intake and other liver diseases. Diet information, including consumption frequency of honey, was assessed by a validated 100-item FFQ. OR with 95 % CI were calculated by the binary logistic regression model, adjusting for confounding factors identified by the directed acyclic graph. Overall, 6513 adults (29·6 %) had NAFLD. Compared with participants consuming ≤1 time/week of honey, the multivariable OR of NAFLD were 0·86 (95 % CI 0·77, 0·97) for 2–6 times/week and 1·10 (95 % CI 0·95, 1·27) for ≥1 times/d (Pfor trend= 0·90). The results were generally similar in subgroups of BMI at a cut-point of 24·0 kg/m2(Pfor interaction= 0·10). In this large-scale study, consuming honey 2–6 times/week was inversely associated with NAFLD, whereas consuming honey ≥1 times/d had no association with NAFLD. These results need replication in other large-scale prospective studies.

21 September 2019 in Molecules
Verified
Journal Article
Open access
PDF file
TZTiantian Zuo
Tiantian Zuo
YQYuexin Qian
Yuexin Qian
CZChunxia Zhang
Chunxia Zhang
YWYuxi Wei
Yuxi Wei
XWXiaoyan Wang
Xiaoyan Wang
WYWen-zhi Yang
Wen-zhi Yang
The state of the art ion mobility quadrupole time of flight (IM-QTOF) mass spectrometer coupled with ultra-high performance liquid chromatography (UHPLC) can offer four-dimensional information supporting the comprehensive multicomponent characterization of traditional Chinese medicine (TCM). Compound Xueshuantong Capsule (CXC) is a four-component Chinese patent medicine prescribed to treat ophthalmic disease and angina. However, research systematically elucidating its chemical composition is not available. An approach was established by integrating reversed-phase UHPLC separation, IM-QTOF-MS operating in both the negative and positive electrospray ionization modes, and a “Component Knockout” strategy. An in-house ginsenoside library and the incorporated TCM library of UNIFITM drove automated peak annotation. With the aid of 85 reference compounds, we could separate and characterize 230 components from CXC, including 155 ginsenosides, six astragalosides, 16 phenolic acids, 16 tanshinones, 13 flavonoids, six iridoids, ten phenylpropanoid, and eight others. Major components of CXC were from the monarch drug, Notoginseng Radix et Rhizoma. This study first clarifies the chemical complexity of CXC and the results obtained can assist to unveil the bioactive components and improve its quality control.

25 March 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
DWDan Wang
Dan Wang
CSChang Shi
Chang Shi
ZGZhen-Hua Ge
Zhen-Hua Ge
YWYu-Xi Wei
Yu-Xi Wei
TLTian-Tian Liu
Tian-Tian Liu
HDHongquan Duan
Hongquan Duan
Background: Guan-Xin-Shu-Tong capsule (GXSTC) is a traditional Chinese medicine (TCM) that has been used to treat coronary heart disease (CHD) for many years in China. However, the holistic mechanism of GXSTC against CHD is still unclear. Therefore, the purpose of this paper was to systematically explore the mechanism of action GXSTC in the treatment of CHD rats using a metabolomics strategy.Methods: A CHD model was induced by ligation of the left anterior descending coronary artery (LAD). In each group, echocardiography was performed; the contents of creatine kinase (CK), lactate dehydrogenase (LDH) and aspartate transaminase (AST) in serum were determined; and the myocardial infarct size was measured. The metabolites in plasma were analyzed by UHPLC-MS/MS-based untargeted metabolomics. Then, multivariate statistical analysis was performed to screen potential biomarkers associated with the GXSTC treatment in the LAD-induced rat CHD model. Finally, the MetaboAnalyst 4.0 platform was used for metabolic pathway enrichment analysis.Results: GXSTC was able to regulate the contents of CK, LDH and AST; restore impaired cardiac function; and significantly reduce the myocardial infarction area in model rats. Twenty-two biomarkers and nine metabolic pathways of GXSTC in the treatment of CHD were identified through UHPLC-MS/MS-based untargeted metabolomics analysis.Conclusion: GXSTC regulates metabolic disorders of endogenous components in LAD-induced CHD rats. The anti-CHD mechanism of GXSTC is mainly related to the regulation of amino acid, lipid and hormonal metabolism. This study provides an overall view of the mechanism underlying the action of GXSTC against CHD.